Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA/SFC for glucose tolerance in mitochondrial diabetes mellitus (MIDD)
jRCTs071200025Completed
- Sponsor
- Neopharma Japan
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in maternally inherited diabetes and deafness (MIDD), sponsored by Neopharma Japan. Started Oct 2020; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
maternally inherited diabetes and deafness (MIDD)
Beyond the preview
Go deeper on jRCTs071200025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200025.